Immunoglobulin Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Immunoglobulin Market to 2027 - Global Analysis and Forecasts By Mode of Delivery (Subcutaneous and Intravenous); Application (Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, and Others); Product (IgA, IgD, IgG, IgE, and IgM)

Report Code: TIPRE00003489 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Immunoglobulins are glycoproteins developed for the response to an immunogen by plasma cells and function as antibodies. Common functions of immunoglobulins are antigen binding and effector functions. Immunoglobulins bind precisely to antigenic determinants and prevent the host from infections. Binding an antibody to antigen has no biological effect but binding antibodies triggers the secondary effector function. Immunoglobulins have receptors for binding with lymphocytes, basophils, phagocytic cells, and platelets.

MARKET DYNAMICS
The immunoglobulin market is anticipated to grow in the forecast period owing to driving factors such as increase in aging population as production of antibody decreases that leads to weaker immune system and rise in number of patients and increasing awareness about the diseases. However, the stringent government regulations toward immunoglobulin products and high risk of side effects owing to the use of immunoglobulin are projected to hamper the market growth.

MARKET SCOPE
The "Global Immunoglobulin Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of immunoglobulin market with detailed market segmentation by mode of delivery, application, product, and geography. The global immunoglobulin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading immunoglobulin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global immunoglobulin market is segmented on the basis of mode of delivery, application and product. Based on mode of delivery, the market is segmented as subcutaneous and intravenous. The immunoglobulin market, based on application is segmented into hypogammaglobulinemia, immunodeficiency disease, multifocal motor neuropathy, Guillain-Barre Syndrome, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and others. By product the Immunoglobulin market is segmented into IgA, IgD, IgG, IgE, and IgM.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global immunoglobulin market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The immunoglobulin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting immunoglobulin market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the immunoglobulin market in these regions.

MARKET PLAYERS
The reports cover key developments in the immunoglobulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from immunoglobulin market are anticipated to lucrative growth opportunities in the future with the rising demand for immunoglobulin market in the global market. Below mentioned is the list of few companies engaged in the immunoglobulin market.

The report also includes the profiles of key immunoglobulin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • ADMA Biologics, Inc.
  • Shire plc
  • CSL Behring LLC
  • China Biologic Products, Inc.
  • Grifols S.A.
  • LFB Biomedicaments S.A.
  • Kedrion S.p.A.
  • Sanquin Plasma Products B.V.
  • Octapharma AG
  • Baxter
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Immunoglobulin Market - By Mode of Delivery
1.3.2 Immunoglobulin Market - By Application
1.3.3 Immunoglobulin Market - By Product
1.3.4 Immunoglobulin Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. IMMUNOGLOBULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. IMMUNOGLOBULIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. IMMUNOGLOBULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. IMMUNOGLOBULINS - GLOBAL MARKET OVERVIEW
6.2. IMMUNOGLOBULINS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF DELIVERY
7.1. OVERVIEW
7.2. MODE OF DELIVERY MARKET FORECASTS AND ANALYSIS
7.3. SUBCUTANEOUS
7.3.1. Overview
7.3.2. Subcutaneous Market Forecast and Analysis
7.4. INTRAVENOUS
7.4.1. Overview
7.4.2. Intravenous Market Forecast and Analysis

8. IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HYPOGAMMAGLOBULINEMIA
8.3.1. Overview
8.3.2. Hypogammaglobulinemia Market Forecast and Analysis
8.4. IMMUNODEFICIENCY DISEASE
8.4.1. Overview
8.4.2. Immunodeficiency Disease Market Forecast and Analysis
8.5. MULTIFOCAL MOTOR NEUROPATHY
8.5.1. Overview
8.5.2. Multifocal Motor Neuropathy Market Forecast and Analysis
8.6. GUILLAIN-BARRE SYNDROME
8.6.1. Overview
8.6.2. Guillain-Barre Syndrome Market Forecast and Analysis
8.7. MYASTHENIA GRAVIS
8.7.1. Overview
8.7.2. Myasthenia Gravis Market Forecast and Analysis
8.8. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
8.8.1. Overview
8.8.2. Chronic Inflammatory Demyelinating Polyneuropathy Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis

9. IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
9.1. OVERVIEW
9.2. PRODUCT MARKET FORECASTS AND ANALYSIS
9.3. IGA
9.3.1. Overview
9.3.2. IgA Market Forecast and Analysis
9.4. IGD
9.4.1. Overview
9.4.2. IgD Market Forecast and Analysis
9.5. IGG
9.5.1. Overview
9.5.2. IgG Market Forecast and Analysis
9.6. IGE
9.6.1. Overview
9.6.2. IgE Market Forecast and Analysis
9.7. IGM
9.7.1. Overview
9.7.2. IgM Market Forecast and Analysis

10. IMMUNOGLOBULIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Immunoglobulin Market Overview
10.1.2 North America Immunoglobulin Market Forecasts and Analysis
10.1.3 North America Immunoglobulin Market Forecasts and Analysis - By Mode of Delivery
10.1.4 North America Immunoglobulin Market Forecasts and Analysis - By Application
10.1.5 North America Immunoglobulin Market Forecasts and Analysis - By Product
10.1.6 North America Immunoglobulin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Immunoglobulin Market
10.1.6.1.1 United States Immunoglobulin Market by Mode of Delivery
10.1.6.1.2 United States Immunoglobulin Market by Application
10.1.6.1.3 United States Immunoglobulin Market by Product
10.1.6.2 Canada Immunoglobulin Market
10.1.6.2.1 Canada Immunoglobulin Market by Mode of Delivery
10.1.6.2.2 Canada Immunoglobulin Market by Application
10.1.6.2.3 Canada Immunoglobulin Market by Product
10.1.6.3 Mexico Immunoglobulin Market
10.1.6.3.1 Mexico Immunoglobulin Market by Mode of Delivery
10.1.6.3.2 Mexico Immunoglobulin Market by Application
10.1.6.3.3 Mexico Immunoglobulin Market by Product
10.2. EUROPE
10.2.1 Europe Immunoglobulin Market Overview
10.2.2 Europe Immunoglobulin Market Forecasts and Analysis
10.2.3 Europe Immunoglobulin Market Forecasts and Analysis - By Mode of Delivery
10.2.4 Europe Immunoglobulin Market Forecasts and Analysis - By Application
10.2.5 Europe Immunoglobulin Market Forecasts and Analysis - By Product
10.2.6 Europe Immunoglobulin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Immunoglobulin Market
10.2.6.1.1 Germany Immunoglobulin Market by Mode of Delivery
10.2.6.1.2 Germany Immunoglobulin Market by Application
10.2.6.1.3 Germany Immunoglobulin Market by Product
10.2.6.2 France Immunoglobulin Market
10.2.6.2.1 France Immunoglobulin Market by Mode of Delivery
10.2.6.2.2 France Immunoglobulin Market by Application
10.2.6.2.3 France Immunoglobulin Market by Product
10.2.6.3 Italy Immunoglobulin Market
10.2.6.3.1 Italy Immunoglobulin Market by Mode of Delivery
10.2.6.3.2 Italy Immunoglobulin Market by Application
10.2.6.3.3 Italy Immunoglobulin Market by Product
10.2.6.4 Spain Immunoglobulin Market
10.2.6.4.1 Spain Immunoglobulin Market by Mode of Delivery
10.2.6.4.2 Spain Immunoglobulin Market by Application
10.2.6.4.3 Spain Immunoglobulin Market by Product
10.2.6.5 United Kingdom Immunoglobulin Market
10.2.6.5.1 United Kingdom Immunoglobulin Market by Mode of Delivery
10.2.6.5.2 United Kingdom Immunoglobulin Market by Application
10.2.6.5.3 United Kingdom Immunoglobulin Market by Product
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Immunoglobulin Market Overview
10.3.2 Asia-Pacific Immunoglobulin Market Forecasts and Analysis
10.3.3 Asia-Pacific Immunoglobulin Market Forecasts and Analysis - By Mode of Delivery
10.3.4 Asia-Pacific Immunoglobulin Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Immunoglobulin Market Forecasts and Analysis - By Product
10.3.6 Asia-Pacific Immunoglobulin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Immunoglobulin Market
10.3.6.1.1 Australia Immunoglobulin Market by Mode of Delivery
10.3.6.1.2 Australia Immunoglobulin Market by Application
10.3.6.1.3 Australia Immunoglobulin Market by Product
10.3.6.2 China Immunoglobulin Market
10.3.6.2.1 China Immunoglobulin Market by Mode of Delivery
10.3.6.2.2 China Immunoglobulin Market by Application
10.3.6.2.3 China Immunoglobulin Market by Product
10.3.6.3 India Immunoglobulin Market
10.3.6.3.1 India Immunoglobulin Market by Mode of Delivery
10.3.6.3.2 India Immunoglobulin Market by Application
10.3.6.3.3 India Immunoglobulin Market by Product
10.3.6.4 Japan Immunoglobulin Market
10.3.6.4.1 Japan Immunoglobulin Market by Mode of Delivery
10.3.6.4.2 Japan Immunoglobulin Market by Application
10.3.6.4.3 Japan Immunoglobulin Market by Product
10.3.6.5 South Korea Immunoglobulin Market
10.3.6.5.1 South Korea Immunoglobulin Market by Mode of Delivery
10.3.6.5.2 South Korea Immunoglobulin Market by Application
10.3.6.5.3 South Korea Immunoglobulin Market by Product
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Immunoglobulin Market Overview
10.4.2 Middle East and Africa Immunoglobulin Market Forecasts and Analysis
10.4.3 Middle East and Africa Immunoglobulin Market Forecasts and Analysis - By Mode of Delivery
10.4.4 Middle East and Africa Immunoglobulin Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Immunoglobulin Market Forecasts and Analysis - By Product
10.4.6 Middle East and Africa Immunoglobulin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Immunoglobulin Market
10.4.6.1.1 South Africa Immunoglobulin Market by Mode of Delivery
10.4.6.1.2 South Africa Immunoglobulin Market by Application
10.4.6.1.3 South Africa Immunoglobulin Market by Product
10.4.6.2 Saudi Arabia Immunoglobulin Market
10.4.6.2.1 Saudi Arabia Immunoglobulin Market by Mode of Delivery
10.4.6.2.2 Saudi Arabia Immunoglobulin Market by Application
10.4.6.2.3 Saudi Arabia Immunoglobulin Market by Product
10.4.6.3 U.A.E Immunoglobulin Market
10.4.6.3.1 U.A.E Immunoglobulin Market by Mode of Delivery
10.4.6.3.2 U.A.E Immunoglobulin Market by Application
10.4.6.3.3 U.A.E Immunoglobulin Market by Product
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Immunoglobulin Market Overview
10.5.2 South and Central America Immunoglobulin Market Forecasts and Analysis
10.5.3 South and Central America Immunoglobulin Market Forecasts and Analysis - By Mode of Delivery
10.5.4 South and Central America Immunoglobulin Market Forecasts and Analysis - By Application
10.5.5 South and Central America Immunoglobulin Market Forecasts and Analysis - By Product
10.5.6 South and Central America Immunoglobulin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Immunoglobulin Market
10.5.6.1.1 Brazil Immunoglobulin Market by Mode of Delivery
10.5.6.1.2 Brazil Immunoglobulin Market by Application
10.5.6.1.3 Brazil Immunoglobulin Market by Product
10.5.6.2 Argentina Immunoglobulin Market
10.5.6.2.1 Argentina Immunoglobulin Market by Mode of Delivery
10.5.6.2.2 Argentina Immunoglobulin Market by Application
10.5.6.2.3 Argentina Immunoglobulin Market by Product

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. IMMUNOGLOBULIN MARKET, KEY COMPANY PROFILES
12.1. ADMA BIOLOGICS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SHIRE PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CSL BEHRING LLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CHINA BIOLOGIC PRODUCTS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GRIFOLS S.A.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LFB BIOMEDICAMENTS S.A.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. KEDRION S.P.A.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANQUIN PLASMA PRODUCTS B.V.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OCTAPHARMA AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BAXTER
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. ADMA Biologics, Inc.
2. Shire plc
3. CSL Behring LLC
4. China Biologic Products, Inc.
5. Grifols S.A.
6. LFB Biomedicaments S.A.
7. Kedrion S.p.A.
8. Sanquin Plasma Products B.V.
9. Octapharma AG
10. Baxter
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book